[1] |
Lei JH, Xu Y, Jiang YF, et al. Clustering cases of Chlamydia psittaci pneumonia in coronavirus disease 2019 screening ward staff[J]. Clin Infect Dis,2021,73(9):e3261-e3265.
|
[2] |
Li NL, Sheng J, Tan WM, et al. Metagenomic next-generation sequencing in the family outbreak of psittacosis: the first reported family outbreak of psittacosis in China under COVID-19[J]. Emerg Microbes Infect,2021,10(1):1418-1428.
|
[3] |
Wallensten A, Fredlund H, Runehagen A. Multiple human-to-human transmission from a severe case of psittacosis, Sweden, January-February 2013[J]. Euro Surveill,2014,19(42):20937.
|
[4] |
Hogerwerf L, DE Gier B, Baan B, et al. Chlamydia psittaci (psittacosis) as a cause of community-acquired pneumonia: a systematic review and meta-analysis[J]. Epidemiol Infect,2017,145(15):3096-3105.
|
[5] |
Qu JM, Zhang J, Chen Y, et al. Aetiology of severe community acquired pneumonia in adults identified by combined detection methods: a multi-centre prospective study in China[J]. Emerg Microbes Infect,2022,11(1):556-566.
|
[6] |
Kozuki E, Arima Y, Matsui T, et al. Human psittacosis in Japan: notification trends and differences in infection source and age distribution by gender, 2007 to 2016[J]. Ann Epidemiol,2020,44:60-63.
|
[7] |
Rybarczyk J, Versteele C, Lernout T, et al. Human psittacosis: a review with emphasis on surveillance in Belgium[J]. Acta Clin Belg,2020,75(1):42-48.
|
[8] |
McGovern OL, Kobayashi M, Shaw KA, et al. Use of real-time PCR for Chlamydia psittaci detection in human specimens during an outbreak of psittacosis--Georgia and Virginia, 2018[J]. MMWR Morb Mortal Wkly Rep,2021,70(14):505-509.
|
[9] |
Yang M, Yang DH, Yang H, et al. Clinical characteristics of Chlamydia psittaci pneumonia infection in Central South China[J]. Infect Dis Ther,2022,11(4):1631-1647.
|
[10] |
沈凌, 田贤江, 梁荣章, 等. 鹦鹉热衣原体肺炎48例临床特征分析[J]. 中华结核和呼吸杂志,2021,44(10):886-891.
|
[11] |
Yin QQ, Li YC, Pan HY, et al. Atypical pneumonia caused by Chlamydia psittaci during the COVID-19 pandemic[J]. Int J Infect Dis,2022,122:622-627.
|
[12] |
Zhang ZJ, Wang PH, Ma CM, et al. Chlamydia psittaci host inflammatory response is the major factor in the progression of pneumonia[J]. Front Immunol,2022,13:929213.
|
[13] |
Shi YF, Chen JX, Shi XH, et al. A case of Chlamydia psittaci caused severe pneumonia and meningitis diagnosed by metagenome next-generation sequencing and clinical analysis: a case report and literature review[J]. BMC Infect Dis,2021,21(1):621-628.
|
[14] |
Meijer R, van Biezen P, Prins G, et al. Multi-organ failure with necrotic skin lesions due to infection with Chlamydia psittaci[J]. Int J Infect Dis,2021,106:262-264.
|
[15] |
刘斌, 谢波, 黄彭, 等. 鹦鹉热衣原体肺炎患者临床特点分析[J]. 中国感染控制杂志,2022,21(2):159-164.
|
[16] |
Duan ZM, GaoYQ, Liu B, et al. The application value of metagenomic and whole-genome capture next-generation sequencing in the diagnosis and epidemiological analysis of psittacosis[J]. Front Cell Infect Microbiol,2022,12:872899.
|
[17] |
Cui L, Qu GG, Chen Y, et al. Polymorphic membrane protein 20G: A promising diagnostic biomarker for specific detection of Chlamydia psittaci infection[J]. Microb Pathog,2021,155:104882.
|
[18] |
国家卫生计生委医政医管局. 国家抗微生物治疗指南(第二版)[M]. 北京: 人民卫生出版社,2019:47.
|
[19] |
马小军, 徐英春, 刘正印. ABX指南-感染性疾病的诊断与治疗(第二版)[M]. 北京: 科学技术文献出版社,2012:296-297.
|
[20] |
王艳泓, 邱玉英, 唐健, 等. 结合宏基因组二代测序诊断的八例鹦鹉热患者临床分析[J]. 中国呼吸与危重监护杂志,2021,20(7):472-478.
|
[21] |
Yang FX, Li JJ, Qi B, et al. Clinical symptoms and outcomes of severe pneumonia caused by Chlamydia psittaci in Southwest China[J]. Front Cell Infect Microbiol,2021,11:727594.
|
[22] |
Donati M, Rodrìguez Fermepin M, Olmo A, et al. Comparative in-vitro activity of moxifloxacin, minocycline and azithromycin against Chlamydia spp[J]. J Antimicrob Chemother,1999,43(6):825-827.
|
[23] |
黄东亚, 苗毅, 蒋奎荣, 等. 重症患者伴高淀粉酶和/或高脂肪酶血症:急性胰腺炎?[J/CD]. 中华重症医学电子杂志,2017,3(2):138-142.
|
[24] |
Yang F, Xu Y, Dong Y, et al. Prevalence and prognosis of increased pancreatic enzymes in patients with COVID-19: A systematic review and meta-analysis[J]. Pancreatology,2022,22(4):539-546.
|
[25] |
Ferakis N, Katsimantas A, Zervopoulos G, et al. Nontraumatic acute elevation of pancreatic enzymes following percutaneous nephrolithotomy: a rare complication[J]. Case Rep Urol,2017,2017:7430328.
|
[26] |
Chaari A, Hakim KA, Rashed N, et al. Factors associated with increased pancreatic enzymes in septic patients: a prospective study[J]. J Intensive Care,2017,5:44.
|
[27] |
李潇, 颜海鹏, 卢秀兰, 等. 盲肠结扎穿孔术建立脓毒症继发胰腺损伤的模型研究[J]. 中国小儿急救医学,2021,28(8):688-691.
|
[28] |
Chaari A, Abdel HK, Bousselmi K, et al. Pancreatic injury in patients with septic shock: A literature review[J]. World J Gastrointest Oncol,2016,8(7):526-31.
|
[29] |
Denz C, Siegel L, Lehmann KJ, et al. Is hyperlipasemia in critically ill patients of clinical importance? An observational CT study[J]. Intensive Care Med,2007,33(9):1633-1636.
|
[30] |
Meczker Á, Hanák L, Párniczky A, et al. Analysis of 1 060 cases of drug-induced acute pancreatitis[J]. Gastroenterology,2020, 159(5):1958-1961. e1-e8.
|
[31] |
Wolfe D, Kanji S, Yazdi F, et al. Methods for the early detection of drug-induced pancreatitis: a systematic review of the literature[J]. BMJ Open,2019,9(11):e027451.
|
[32] |
Chadalavada P, Simons-Linares CR, Chahal P. Drug-induced acute pancreatitis: prevalence, causative agents, and outcomes[J]. Pancreatology,2020,20(7):1281-1286.
|
[33] |
Wolfe D, Kanji S, Yazdi F, et al. Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations[J]. PLoS One,2020,15(4):e0231883.
|